Tag
10 articles
Bristol Myers Squibb has acquired Nvidia's DGX SuperPOD based on the Vera Rubin architecture, becoming the first life sciences company to do so. The system will accelerate drug discovery and development through advanced AI capabilities.
AWS GraphRAG deployment has slashed drug research cycles by 87% by unifying fragmented databases into a single queryable knowledge graph. This advancement significantly accelerates the early stages of drug discovery and improves success rates.
This article explains how artificial intelligence (AI) is revolutionizing drug discovery, especially for neglected diseases. Learn how AI can speed up the process of finding new medicines and make treatments more accessible to people with rare conditions.
ByteDance's Anew Labs, known for building TikTok's recommendation algorithm, is now using AI to design drugs for previously 'undruggable' diseases.
Learn how artificial intelligence is revolutionizing drug discovery by helping researchers identify promising new molecules faster and more efficiently than ever before.
Amazon Web Services has launched Amazon Bio Discovery, an AI-powered platform designed to accelerate early-stage drug discovery in the pharmaceutical industry.
This article explains how artificial intelligence (AI) is revolutionizing the pharmaceutical industry by helping scientists discover new medicines faster. It explores the concept of AI pharma and how a major tech company invested $400 million in a tiny AI startup developing new treatments.
Learn how to use AI-powered tools for drug discovery by analyzing molecular structures and predicting drug properties using Python and machine learning.
Accumulus Technologies launches a live integration layer connecting pharma systems to national drug regulators across 70+ countries, streamlining global drug approvals.
Zurich-based startup Rivia has raised €13 million to develop agentic AI systems that will streamline clinical trial operations and improve efficiency in drug development.
